Product identification
Medicine name:
HATCHPAK IB H120
HATCHPAK IB H120, замразена суспензия за пулверизиране
Active substance:
- Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
-
Chicken (one day-old chick)
Route of administration:
-
Oculonasal use
Product details
Active substance and strength:
-
Avian infectious bronchitis virus, type Massachusetts, strain H120, Live3.70/log 10 50% embryo infective dose1.00Dose
Pharmaceutical form:
-
Concentrate for nebuliser solution
Withdrawal period by route of administration:
-
Oculonasal use
- Chicken (one day-old chick)
-
All relevant tissuesno withdrawal periodWithdrawal period is 0 days
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Package description:
- Container of liquid nitrogen of canisters of 4 yellow ampoules of 15,000 doses
- Container of liquid nitrogen of canisters of 4 yellow ampoules of 10,000 doses
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Authorisation number:
- 0022-2083
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0171/001
Concerned member states:
-
Belgium
-
Bulgaria
-
Cyprus
-
Czechia
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Romania
-
Slovakia
-
Slovenia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet